A detailed history of Qube Research & Technologies LTD transactions in Natera, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 327,628 shares of NTRA stock, worth $47.9 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
327,628
Previous 436,993 25.03%
Holding current value
$47.9 Million
Previous $47.3 Million 12.0%
% of portfolio
0.06%
Previous 0.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$97.75 - $129.67 $10.7 Million - $14.2 Million
-109,365 Reduced 25.03%
327,628 $41.6 Million
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $29.5 Million - $38.9 Million
345,550 Added 377.89%
436,993 $47.3 Million
Q1 2024

May 14, 2024

BUY
$59.21 - $92.9 $4.64 Million - $7.28 Million
78,332 Added 597.45%
91,443 $8.36 Million
Q4 2023

Feb 13, 2024

SELL
$37.55 - $62.64 $1.22 Million - $2.03 Million
-32,474 Reduced 71.24%
13,111 $821,000
Q3 2023

Nov 13, 2023

SELL
$43.4 - $62.52 $8.74 Million - $12.6 Million
-201,386 Reduced 81.54%
45,585 $2.02 Million
Q2 2023

Aug 14, 2023

BUY
$47.08 - $55.16 $3.34 Million - $3.91 Million
70,960 Added 40.32%
246,971 $12 Million
Q1 2023

May 15, 2023

BUY
$36.57 - $58.29 $6.44 Million - $10.3 Million
176,011 New
176,011 $9.77 Million
Q2 2022

Aug 15, 2022

SELL
$28.13 - $44.54 $661,673 - $1.05 Million
-23,522 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$30.32 - $91.33 $713,187 - $2.15 Million
23,522 New
23,522 $957,000
Q4 2021

Feb 01, 2022

SELL
$86.26 - $119.0 $2 Million - $2.76 Million
-23,167 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$100.17 - $126.36 $7.93 Million - $10 Million
-79,190 Reduced 77.37%
23,167 $2.58 Million
Q2 2021

Aug 13, 2021

BUY
$86.05 - $119.72 $8.58 Million - $11.9 Million
99,753 Added 3830.76%
102,357 $11.6 Million
Q1 2021

May 14, 2021

BUY
$91.47 - $124.36 $238,187 - $323,833
2,604 New
2,604 $264,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.